The aim of this study was to compare the effect of controlled-release monensin on the automatic registered body condition score (BCS), and biomarkers registered using a fully automated inline analyzer, such as milk β-hydroxybutyrate (BHB), milk yield (MY) and milk lactate dehydrogenase (LDH). Two experimental groups were formed: (1) monensin group (GK) supplemented with monensin (a monensin controlled release capsule (MCRC) of 32.4 g, n = 42) and (2) control group (GO) (capsule containing no monensin, n = 42). Treatment began 21 days before calving, and the experiment was finished one month after calving. In order to gather data about MY, BHB, and LDH, Herd Navigator a real-time analyzer (Lattec I/S, Hillerød, Denmark) was used together with a DeLaval milking robot (DeLaval Inc., Tumba, Sweden). BCS was measured using 3D BCS cameras (DeLaval, DeLaval International AB). All data were registered at one, 15 and 30 days after calving. The statistical analysis was performed using SPSS 26.0 (SPSS Inc., Chicago, USA) package. It was concluded that in the group of cows with monensin supplement (a monensin controlled release capsule of 32.4 g,), the body condition score was statistically significantly higher at the 15th (+0.24, p=0.003) and 30th (+0.52, p<0.001) days after calving, the productivity of cows in this group increased by 10.25% from the 1st to the 15th day and by 22.49% from the beginning of the experiment to the 30th day (p<0.001), lactate dehydrogenase activities at the 15th and 30th days after calving in this group were lower (p<0.001), and also in this group, the number of cows with a value of β-hydroxybutyrate of 0.06 mmol/L decreased from the beginning of the experiment to 30 days after calving by 4.70% (from 19.00% to 14.30%) compared with the control group.
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.